These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 38590557)

  • 1. Role of co‑inhibitory molecules in the treatment of psoriasis (Review).
    Yao Y; Zeng L; Huang X; Zhang J; Zhang G; Wang L
    Exp Ther Med; 2024 May; 27(5):209. PubMed ID: 38590557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Co-Signaling Molecules in Psoriasis and Their Implications for Targeted Treatment.
    Liu S; Xu J; Wu J
    Front Pharmacol; 2021; 12():717042. PubMed ID: 34354596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-signaling molecules in psoriasis pathogenesis: implications for targeted therapy.
    Lin X; Huang T
    Hum Immunol; 2015 Mar; 76(2-3):95-101. PubMed ID: 25636578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis.
    Yu Y; Chen Z; Wang Y; Li Y; Lu J; Cui L; Yu Z; Ding Y; Guo C; Zhang X; Shi Y
    Int Immunopharmacol; 2021 Jul; 96():107722. PubMed ID: 33965878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.
    Zhang LJ
    Front Immunol; 2019; 10():1440. PubMed ID: 31293591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells.
    Agrawal B; Gupta N; Konowalchuk JD
    Front Immunol; 2018; 9():2391. PubMed ID: 30405607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratin 6, 16 and 17-Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis.
    Zhang X; Yin M; Zhang LJ
    Cells; 2019 Aug; 8(8):. PubMed ID: 31374826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis.
    Prinz JC
    Front Immunol; 2018; 9():954. PubMed ID: 29760713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Role of Inhibitory Receptors in the Treatment of Psoriasis.
    Shah N; Sandigursky S; Mor A
    Bull Hosp Jt Dis (2013); 2017 May; 75(3):155-163. PubMed ID: 28902599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second- and third-generation drugs for immuno-oncology treatment-The more the better?
    Dempke WCM; Fenchel K; Uciechowski P; Dale SP
    Eur J Cancer; 2017 Mar; 74():55-72. PubMed ID: 28335888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting lymphocyte co-stimulation: from bench to bedside.
    Felix NJ; Suri A; Salter-Cid L; Nadler SG; Gujrathi S; Corbo M; Aranda R
    Autoimmunity; 2010 Nov; 43(7):514-25. PubMed ID: 20429850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention.
    Norde WJ; Hobo W; van der Voort R; Dolstra H
    Blood; 2012 Jul; 120(4):728-36. PubMed ID: 22563087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin?
    Valdimarsson H; Sigmundsdóttir H; Jónsdóttir I
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():21-4. PubMed ID: 9020931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
    Albanesi C; De Pità O; Girolomoni G
    Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights of T cells in the pathogenesis of psoriasis.
    Cai Y; Fleming C; Yan J
    Cell Mol Immunol; 2012 Jul; 9(4):302-9. PubMed ID: 22705915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
    Abrams JR; Kelley SL; Hayes E; Kikuchi T; Brown MJ; Kang S; Lebwohl MG; Guzzo CA; Jegasothy BV; Linsley PS; Krueger JG
    J Exp Med; 2000 Sep; 192(5):681-94. PubMed ID: 10974034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of perforin mediated cell cytotoxicity in psoriasis].
    Kastelan M; Massari LP; Peternel S
    Lijec Vjesn; 2010; 132(11-12):361-4. PubMed ID: 21294326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis, multi-omics research, and clinical treatment of psoriasis.
    Yu J; Zhao Q; Wang X; Zhou H; Hu J; Gu L; Hu Y; Zeng F; Zhao F; Yue C; Zhou P; Li G; Li Y; Wu W; Zhou Y; Li J
    J Autoimmun; 2022 Dec; 133():102916. PubMed ID: 36209691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Inflammatory Action of Keratinocyte-Derived Vaspin: Relevance for the Pathogenesis of Psoriasis.
    Saalbach A; Tremel J; Herbert D; Schwede K; Wandel E; Schirmer C; Anderegg U; Beck-Sickinger AG; Heiker JT; Schultz S; Magin T; Simon JC
    Am J Pathol; 2016 Mar; 186(3):639-51. PubMed ID: 26783881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.